TP53 and cancer: Our observations from lack of co-immunoprecipitation between p53 and the SARS-CoV-2 spike S2 protein subunit are consistent with different cellular locations of SARS-CoV-2 spike and p53 in the cancer cells treated with cisplatin (Figure 1C).